Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
Retrieved on:
Thursday, March 16, 2023
Developed with the Company’s proprietary Physiomimic Technology™ platform, the PKU GOLIKE family of products are next-generation, prolonged-release amino acid medical foods for the dietary management of phenylketonuria (PKU).
Key Points:
- Developed with the Company’s proprietary Physiomimic Technology™ platform, the PKU GOLIKE family of products are next-generation, prolonged-release amino acid medical foods for the dietary management of phenylketonuria (PKU).
- The new PKU GOLIKE BARs come in tropical and red fruit flavors and contain natural ingredients and real fruit.
- To learn more about the features of the new PKU GOLIKE BARs, watch the following video: https://youtu.be/tI_UxCRCedw
“Our team has spent the past four years conducting focus groups and qualitative research, working directly with patients, caregivers and healthcare providers in the PKU community to develop the new PKU GOLIKE BARs,” said Jack Weinstein, chief executive officer of Relief Therapeutics. - “The new PKU GOLIKE BARs were developed with patients and for patients to address the needs expressed by patients.